Founded in November 2009, Paindure is developing a biodegradable implant-based product enabling minimally invasive localized targeted therapy for treating migraine headaches.

Treatment involves administering a long-term (6 month) local anesthetic. Prototype development can be completed within a 12-18 month period.

Patents were provisionally submitted in March 2009 regarding new use drug combination, a new combination of formulation (slow release) and new administration.